Thanks PDS!
Yes, @Dms324 - so far as we know, the B-vaxx Phase 2 trial is still scheduled to end in December this year. It gets very little attention, but the results could be interesting.
At the very least it has already shown that the B-cell immunotherapy approach used in B-vaxx, (and also Her-vaxx and PD1-vaxx) is incredibly safe and produces a strong immune response with no significant side effects or toxicity. The Her-vaxx and PD1-vaxx trials (to date) have shown the same excellent safety profile - so IMU has extremely good evidence that the B-cell platform is very very safe. Now we await further confirmation of efficacy.
Cheers
Dave
Thanks PDS!Yes, @Dms324 - so far as we know, the B-vaxx Phase 2...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.2¢ |
Change
0.001(1.41%) |
Mkt cap ! $527.0M | |||
| Open | High | Low | Value | Volume |
| 7.2¢ | 7.6¢ | 7.1¢ | $2.390M | 32.54M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 1642723 | 7.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.3¢ | 68400 | 1 |
View Market Depth
| Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.3¢ |
Change
0.001 ( 2.24 %) |
||||
| Open | High | Low | Volume | ||
| 7.1¢ | 7.6¢ | 7.1¢ | 9279379 | ||
| Last updated 15.58pm 17/05/2024 ? | |||||
| IMU (ASX) Chart |